|
FOCUS ON TRANSLATIONAL RESEARCH |
|
|
|
By Cell & Gene: The Podcast | Episode 133 of Cell & Gene: The Podcast features Host Erin Harris' discussion with Aprea Therapeutics' CEO, Dr. Oren Gilad. They cover the evolution of precision oncology, the science of synthetic lethality, and how Aprea is developing next-generation therapies that target cancer's unique genetic vulnerabilities while improving safety and efficacy. | |
|
|
| Optimizing Gene Expression Analysis With ddPCR | Application Note | Bio-Rad Laboratories, Inc. | Explore how one-step and two-step digital PCR workflows elevate sensitivity and efficiency, ensuring reliable RNA quantification for complex studies. |
|
|
|
| What FDA CRLs Reveal About CCIT | White Paper | Solvias | FDA rejection letters show common CCIT gaps — low sensitivity and incomplete validation. Spotting these trends helps teams strengthen integrity testing and avoid approval delays. |
|
|
|
|
| Bridging Discovery And CMC With Rapid Pools | Webinar | Asimov | Learn how early stable CHO expression data reveals manufacturability issues in complex antibodies that transient screening misses, with case studies showing how this changes lead selection. |
|
|
| What Is Transfection? | Article | Mirus Bio | Review core transfection principles essential for assessing gene function and advancing applications across therapeutic development pipelines. |
|
|
TRANSLATIONAL RESEARCH SOLUTIONS |
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
